Ilex Capital Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,098,306
Closed -$78.2M 157
2026
Q1
$78.2M Buy
1,098,306
+587,838
+115% +$46.4M 1.93% 19
2025
Q4
$41.9M Sell
510,468
-244,009
-32% -$19M 1.18% 31
2025
Q3
$56.7M Buy
754,477
+150,375
+25% +$11.2M 1.81% 20
2025
Q2
$44.7M Buy
+604,102
New +$42.1M 1.48% 26
2025
Q1
Sell
-443,625
Closed -$34.7M 196
2024
Q4
$34.7M Sell
443,625
-31,309
-7% -$2.66M 2.22% 20
2024
Q3
$44.6M Buy
+474,934
New +$39.9M 3% 15
2024
Q1
Sell
-384,780
Closed -$29.8M 23
2023
Q4
$29.8M Buy
+384,780
New +$26.9M 4.16% 10

Other funds holding GEHC

Ilex Capital Partners's GEHC Position: Q2 2026 in Review

Ilex Capital Partners sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 1,098,306 shares — an estimated $78.2M sold.

Ilex Capital Partners first reported a position in GEHC in Q4 2023 and held it in 7 quarters. The position peaked at $78.2M in Q1 2026. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Ilex Capital Partners reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Ilex Capital Partners sold 1,098,306 GE HealthCare shares in Q2 2026, an estimated $78.2M.
  • Ilex Capital Partners first reported a position in GE HealthCare in Q4 2023 and held it in 7 quarters.
  • Ilex Capital Partners's GE HealthCare position peaked at $78.2M in Q1 2026.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.